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HCN channels are a novel therapeutic target for cognitive
dysfunction in Neuroﬁbromatosis type 1
A Omrani1,2,10, T van der Vaart1,2,3, E Mientjes1,2, GM van Woerden1,2, MR Hojjati1,4, KW Li5, DH Gutmann6, CN Levelt7, AB Smit5,
AJ Silva8, SA Kushner2,9 and Y Elgersma1,2
Cognitive impairments are a major clinical feature of the common neurogenetic disease neuroﬁbromatosis type 1 (NF1). Previous
studies have demonstrated that increased neuronal inhibition underlies the learning deﬁcits in NF1, however, the molecular
mechanism underlying this cell-type speciﬁcity has remained unknown. Here, we identify an interneuron-speciﬁc attenuation of
hyperpolarization-activated cyclic nucleotide-gated (HCN) current as the cause for increased inhibition in Nf1 mutants.
Mechanistically, we demonstrate that HCN1 is a novel NF1-interacting protein for which loss of NF1 results in a concomitant
increase of interneuron excitability. Furthermore, the HCN channel agonist lamotrigine rescued the electrophysiological and
cognitive deﬁcits in two independent Nf1 mouse models, thereby establishing the importance of HCN channel dysfunction in NF1.
Together, our results provide detailed mechanistic insights into the pathophysiology of NF1-associated cognitive defects, and
identify a novel target for clinical drug development.
Molecular Psychiatry advance online publication, 28 April 2015; doi:10.1038/mp.2015.48
INTRODUCTION
Neuroﬁbromatosis type 1 (NF1, incidence 1:3000) is caused by
mutations in the NF1 gene. The NF1 gene product, neuroﬁbromin,
contains a Ras GTPase-activating protein domain, which serves as
a negative regulator of Ras/ERK signaling. The clinical symptoms
of NF1 include cutaneous neuroﬁbromas, café-au-lait spots,
skinfold freckling and Lisch nodules, as well as cognitive deﬁcits
that negatively impact school performance and quality of life.1,2
Mice with a heterozygous null mutation of the Nf1 gene
(Nf1+/–mice) closely model the cognitive deﬁcits and behavioral
difﬁculties experienced by human NF1 patients, including
visual-spatial learning, working memory, attention and motor
performance deﬁcits.3–5
Previously, it has been shown that the learning deﬁcits of Nf1+/–
mice result from hyperactivation of Ras signaling in GABAergic
neurons, despite expression of the neuroﬁbromin/Ras in both
excitatory and inhibitory neurons.3,6 The speciﬁcity of this
phenotype is further surprising, given that it is not recapitulated
in other mouse models in which Ras-ERK signaling is upregulated,
such as mouse models for Noonan syndrome and Costello
syndrome.7 This suggests that NF1 might also have a Ras-
independent function in neurons. Ras-independent targets hold
substantial therapeutic potential, as Ras itself is difﬁcult to target,
and drugs that interfere with downstream Ras signaling have poor
tissue speciﬁcity and undesirable side effects, limiting their utility
for treating cognitive dysfunction. Moreover, two randomized
controlled trials targeting Ras activity in NF1 patients demon-
strated no evidence of clinical efﬁcacy.8,9
In the present study, we sought to deﬁne the mechanisms
underlying the cell-type-speciﬁc pathophysiology underlying the
learning deﬁcits of Nf1 mice. Given the widespread expression of
neuroﬁbromin in neuronal and glial cell types, we focused our
efforts on a novel Nf1 mouse mutant with deletion of the neuron-
speciﬁc NF1 exon 9a isoform (Nf19a–/9a). Exon 9a is a short 10
amino-acid sequence in the amino-terminal region, the presence
of which does not inﬂuence the function of the Ras GTPase-
activating protein domain.10 Expression of the exon 9a isoform
begins postnatally and is highly abundant in the septum, striatum,
cortex and hippocampus.10–12 We found that Nf19a–/9a– mice
recapitulate the phenotypes observed in the global Nf1+/– mice,
including deﬁcits in hippocampal synaptic plasticity and learning,
as well as enhanced inhibitory synaptic transmission. Furthermore,
we identiﬁed the hyperpolarization-activated cyclic nucleotide-
gated channel 1 (HCN1) as a neuroﬁbromin-interacting protein.
HCN1 belongs to the family of voltage-gated ion channels that
mediate an inward cationic current (Ih),
13 which contributes to
intrinsic excitability, pacemaker activity and synaptic integra-
tion.14–16 Accordingly, increasing evidence has implicated Ih
in activity-dependent plasticity, learning and memory, and
epilepsy.17–21 Furthermore, HCN1 is enriched in cortical and
hippocampal parvalbumin-expressing interneurons.22–26 We now
demonstrate attenuation of Ih and subsequent enhancement of
excitability in interneurons of Nf1 mutant mice. Moreover, we
show that the attenuation of Ih underlies the increased inhi-
bitory neurotransmission in Nf19a–/9a– and Nf1+/– mice, such that
increasing HCN current with lamotrigine (LTG) rescues the
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electrophysiological and learning deﬁcits in both Nf19a–/9a– and
Nf1+/– mice.
MATERIALS AND METHODS
Animals
Experimental mice were obtained by crossing Nf19a–/9a+ mice (in C57BL/
6JOlaHsd background) with 129T2/SvEmsJ (Jackson Laboratories, Bar
Harbor, ME, USA) by crossing the obtained F1 mutant mice with each
other to get homozygous Nf19a–/9a– mutants and wild-type (WT) littermates
in the hybrid B6/129T2 background, comparable to that of previous studies
in NF1. Homozygous Nf19a–/9a– mice were born at the expected Mendelian
frequency, and were indistinguishable from WT mice upon examination by
an experienced observer. Male Nf1+/– mice (C57BL/6JOlaHsd, 430
generations) were crossed once with WT 129T2/SvEmsJ mice (Jackson
Laboratories) to obtain F1 hybrid B6/129T2 heterozygous mutant and WT
control mice. H-RasG12V mice in C57BL/6JOlaHsd background were
obtained by crossing heterozygous H-RasG12V mice to yield homozygous
H-RasG12V mice and WT control mice. For all experiments, we used both
male and female mice. All mice were between 8 and 15 weeks of age at
the start of the behavioral experiments, housed in groups of 2–4 per cage,
on a 12-h light/dark cycle between 0700 and 1900 hours, and fed standard
laboratory food ad libitum. All included animals were healthy (discomfort
score 0). Behavioral experiments were performed between 1200 and
1800 hours. For ex-vivo experiments, mice were killed between 0900 and
1200 hours. Experimenters were blind for genotype and treatment. All
experiments were approved by the Dutch Ethical Committee and were in
accordance with the institutional animal care and use committee
guidelines.
Slice electrophysiology
Hippocampal slices were prepared from the brains of 3- to 4-week-old and
adult mice using standard techniques. Field excitatory postsynaptic
potentials (EPSPs) were evoked in CA3-CA1 synapses and whole-cell
patch-clamp recording were performed from hippocampal CA1 pyramidal
neurons and interneurons. For interneurons recordings, 0.2% biocytin was
included in the intracellular pipette solution for later morphological
identiﬁcation of the recorded cells. Standard protocols were followed for
recording and data analysis. For additional information, see Supplementary
Materials and Methods.
Morris water maze
The water maze task was performed as previously described.27 Before
performing the water maze task, the mice were handled for a week. For
initial characterization of Nf19a–/9a–mice, training consisted of 4 trials
per day, divided in two sessions of two trials with a 1 h interval (Figure 1) or
two trials per day for LTG-treated mice. At the start of the ﬁrst session the
mice were placed on the platform for 30 s. Then they were placed in the
water at a pseudo-random start position and allowed to ﬁnd the platform
for 60 s. If the mice did not ﬁnd the platform within 60 s, it was placed onto
the platform and allowed to remain on it for 30 s. The platform position
remained at the same position during all trials. Spatial memory was
assessed with a probe trial given 1–2 h (Figure 1d) or 22–24 h after the last
training trial (Figure 5), when the majority of the mice was able to locate
the platform in less than 30 s (after 3 training days for mice in Figure 1d
and 5e and after 5 training days for Figure 5d). During probe trials mice
were placed on the platform for 30 s, after which the platform was
removed from the pool and the mice were placed in the pool at the
opposite side of the previous platform position. The mice were then
allowed to search for the platform for 60 s. The visible water maze was
performed with a new group of mice. After the handling period, mice were
trained in the pool to ﬁnd the escape platform which was ﬂagged with a
small cue on the top of the platform. The platform location and the start
position were changed on every trial and each mouse received four trials
per day for 8 consecutive days. Mice were excluded from further analysis if
they showed excessive (420%) ﬂoating (throughout the training or at the
probe trial itself), or would not stay on the platform after training day 2.
With respect to exclusion criteria, no differences between genotypes were
observed (typically 1–2 mice per genotype are excluded).
Rotarod
Motor learning was assessed with the accelerating rotarod (Ugo Basile,
Comerio Varese, Italy) as previously described.5 Each animal was placed on
a 3-cm diameter cylinder, accelerated from 4 to 40 r.p.m. for maximum
5min. All animals were given ﬁve trials during one day, with an inter-trial
interval of 45 min. The latency time to fall was measured in seconds.
Statistical analysis
All data are reported as means± s.e.m. Cumulative miniature and
spontaneous synaptic currents amplitude and inter-event interval distribu-
tions were analyzed for statistical signiﬁcance using the Kolmogorov–
Smirnov test (Mini Analysis), and a conservative critical probability level of
Po0.01. All other statistical tests, including t-tests and one- or two-way
analysis of variance, were performed using a critical probability of Po0.05
and two-sided testing (Prism, GraphPad Software, Inc., La Jolla, CA, USA
and SPSS, IBM Corporation, Armonk, NY, USA). Post hoc analyses were
performed only when an analysis of variance yielded a signiﬁcant
(Po0.05) main effect.
RESULTS
Nf19a–/9a– mice have impaired spatial learning and synaptic
plasticity
We generated a novel Nf1 mouse model (the homozygous
Nf19a–/9a– mutant), in which the neuron-speciﬁc NF1 exon 9a-
containing isoform is deleted. Reverse transcription-quantitative
PCR conﬁrmed the total absence of Nf1 exon 9a-containing mRNA
in Nf19a–/9a– mice (Figure 1a and Supplementary Figure 1).
Consistent with the relatively high abundance of this neuronal
isoform in the hippocampus, total Nf1 mRNA was reduced by
36± 7% (n= 9, Figure 1b), with concomitant reduction of total
neuroﬁbromin protein (a reduction of 39 ± 2% in the hippocam-
pus, n= 11; Figures 1b and c). Nf19a–/9a– mice were born at the
expected Mendelian frequency and appeared healthy. Notably,
and in contrast to Nf1+/– mice,5 Nf19a–/9a– mice have no detectable
motor impairments (Supplementary Figure 2a).
Visual-spatial problems are among the most frequent cognitive
deﬁcits observed in NF1 patients.28 Therefore, Nf19a–/9a– mice were
tested in the Morris water maze task previously demonstrated to
be impaired in Nf1+/–mice.3,4,29 Indeed, Nf19a–/9a– mice utilized an
exclusively non-spatial search strategy and showed no preference
for the target quadrant (Figure 1d). Analogous to Nf1+/– mice, this
deﬁcit was not the result of decreased motivation or impaired
swimming performance, given that Nf19a–/9a– mice showed no
changes in swimming speed, thigmotaxis or the ability to learn
the visible platform version of the water maze (Supplementary
Figures 2b and e). These results indicate that intact expression of
the neuron-speciﬁc Nf1 exon 9a isoform is required for normal
spatial learning.
To determine whether the spatial learning impairments of
Nf19a–/9a– mutants are associated with changes in synaptic func-
tion, we recorded ﬁeld excitatory postsynaptic potentials from
hippocampal Schaffer collateral-CA1 synapses. No signiﬁcant
differences were found between Nf19a–/9a– and WT mice in baseline
synaptic transmission or paired-pulse ratio (Supplementary Figures
2f,g). Long-term potentiation (LTP) was induced by theta burst
stimulation (TBS), a form of stimulation that mimics endogenous
hippocampal activity during spatial exploration.30 In contrast to
their WT littermates, Nf19a–/9a– mice showed a signiﬁcant deﬁcit in
TBS-induced LTP (Figure 1e). Consistent with the sensitivity of TBS-
induced LTP to changes in GABAergic inhibition,31 LTP was normal
when induced using a high-frequency stimulation (HFS) protocol
(Figure 1f). Furthermore, partial block of inhibitory neurotransmission
with picrotoxin (10 μM) fully restored TBS-induced LTP in Nf19a–/9a–
mice (Figure 1g). Given the similarities to Nf1+/– mice,3,6 we
reasoned that the neuron-speciﬁc Nf19a–/9a– mice might share a
similar GABAergic mechanism underlying the learning deﬁcits.
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Nf19a–/9a– mice show increased inhibition
To further characterize changes in inhibition, we measured evoked
monosynaptic inhibitory postsynaptic potentials using whole-cell
recordings from CA1 pyramidal neurons. Notably, inhibitory
postsynaptic potential amplitude was bigger at higher stimulus
levels in Nf19a–/9a–mice, whereas paired-pulse ratio was reduced,
suggesting a change in presynaptic GABA release (Figure 2a).
Spontaneous miniature inhibitory postsynaptic currents recorded
from Nf19a–/9a– and WT mice showed no signiﬁcant differences
in normal artiﬁcial cerebrospinal ﬂuid. However, enhancing
synaptic GABA release by depolarizing synaptic terminals with
high extracellular potassium (12.5 mM) resulted in a signiﬁcantly
increased miniature inhibitory postsynaptic current frequency (but
not amplitude) in Nf19a–/9a– neurons compared with WT controls
(Figures 2b and c). This phenotype is similar to Nf1+/– mice6 and
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Figure 1. Characterization of the Nf19a–/9a– mutant. (a) Results of the reverse transcription-PCR in cortex and hippocampus in WT and Nf19a–/9a–
mice showing loss of Nf1 exon 9a-containing transcripts in Nf19a–/9a– mice (representative image, quantitative PCR experiment performed on 7
WT and 9 mutant mice). (b) Western blots of cortical and hippocampal lysates of the WT and Nf19a–/9a– mice showing reduction of total
neuroﬁbromin levels in the mutants (representative image, experiment performed on 10 WT and 11 mutant mice). (c) Nf1 mRNA (Nf19a–/9a–:
n= 9; WT: n= 7, Po0.01) and neuroﬁbromin protein (Nf19a–/9a–: n= 11; WT: n= 10, Po0.001) in the hippocampus of WT and Nf19a–/9a–mice.
(d) In the water maze probe trial, Nf19a–/9a– mice show no signiﬁcant spatial learning, while WT mice show a clear preference for the target
quadrant (TQ, black column) (Nf19a–/9a–: n= 15, P = 0.6; WT: n= 14, Po0.001, paired t-test between target and average of other quadrants).
Bars represent target, adjacent right, opposite, and adjacent left quadrants, respectively. The heat-plots are a visual representation of all search
tracks, in which the color indicates the mean time spent at a certain position. The black circle indicates the target platform position used
during training. (e) LTP deﬁcit at Schaffer collateral-CA1 synapses in Nf19a–/9a–mice induced by TBS (WT: n= 14 and Nf19a–/9a–: n= 15; Po0.02)
but not by an (f) High frequency stimulation (WT: n= 13 and Nf19a–/9a–: n= 15, P= 0.8). (g) Picrotoxin (PTX) restores TBS-LTP in Nf19a–/9a– mice
(WT: n= 14 and Nf19a–/9a–: n= 17, P= 0.9). Insets are ﬁeld excitatory postsynaptic potentials (fEPSPs) in WT and Nf19a–/9a–mice taken at
the points shown in each graph. Calibration: 5 ms and 0.2 mV. Statistical analyses were performed by Student’s t-test. *Po0.05, **P o0.01.
Data represent the mean± s.e.m.
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consistent with the observed increase of evoked inhibitory
postsynaptic potential amplitude at higher stimulus intensities.
Taken together, these results indicate that enhanced GABA release
underlies the increased inhibition in Nf19a–/9a– mutant mice.
We subsequently characterized excitatory synaptic transmission
in CA1 pyramidal cells. Consistent with a selective modulation of
inhibition, no signiﬁcant differences were observed for evoked
excitatory postsynaptic potentials (EPSPs) or paired-pulse ratio
(Figure 2d). In addition, the frequency and amplitude of miniature
excitatory postsynaptic currents were normal, recorded in both
standard and high extracellular potassium (Figures 2e and f).
Taken together, our results demonstrate that the synaptic
abnormalities seen in Nf19a–/9a– mice are speciﬁc for inhibitory
neurons, and closely resemble those of Nf1+/–mice. This ﬁnding in
Nf19a–/9a– mice is an important and independent replication of the
previously described phenotype of Nf1+/– mice,6 emphasizing the
importance of GABAergic dysfunction in the pathophysiology
of NF1.
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Figure 2. Enhanced inhibition in Nf19a–/9a– mice. (a) Evoked inhibitory postsynaptic potentials (IPSPs) show larger amplitude in mutants (two-
way analysis of variance (ANOVA), F1,16 = 5.3; Po0.05; n= 9 for both groups) and paired-pulse ratio is reduced in Nf19a–/9a– compared with WT
controls (0.6± 0.04, n= 10 vs 0.8± 0.05, n= 7; Po0.02). (b) Representative traces (top) and cumulative distributions of miniature inhibitory
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distribution during baseline or high KCl conditions (P= 0.35). (f) Group data of mEPSC frequency in baseline and high KCl conditions (WT:
0.9± 0.1 Hz vs 1.26± 0.1 Hz, n= 9, Po0.05; Nf19a–/9a–: 0.8± 0.1 Hz, vs 1.25± 0.1 Hz, n= 10, Po0.05). The ratio of mean frequency of mEPSC in
high KCl to that in baseline conditions is unchanged (P= 0.9). Calibration: 500ms and 100 pA. *Po0.05, **P o0.01. Data represent the
mean± s.e.m.
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HCN1 co-immunoprecipitates and co-localizes with NF1
Previous studies have identiﬁed NF1-interacting proteins, both
within and beyond the Ras signaling pathway. Therefore, we
sought to utilize the neuron-speciﬁc exon 9a mutants, to perform
an unbiased and focused comparative proteomics approach for
uniquely identifying binding partners of NF1 speciﬁcally in
neurons. Lysates prepared from WT and Nf19a–/9a– mice were
used for co-immunoprecipitation (co-IP) with anti-neuroﬁbromin
antibody followed by mass spectrometry for protein identiﬁcation.
In addition to the previously identiﬁed neuroﬁbromin-interacting
proteins, tubulin and actin,32,33 we identiﬁed HCN1 as a novel
putative neuroﬁbromin-interacting protein (Supplementary
Table 1). HCN1 is a particularly compelling candidate, given its
well-established role in regulating neuronal excitability. Moreover,
HCN1 has been previously found to have prominent enrichment
in cortical and hippocampal GABAergic neurons, in particular
parvalbumin-expressing interneurons.22–26 The proteomics ﬁnd-
ings were conﬁrmed by western blot analysis of immunoprecipi-
tated proteins from Nf19a–/9a– and WT lysates (Figure 3a). Although
there was a trend toward reduced amounts of co-precipitated
HCN in the Nf19a–/9a– mutants, this difference was not signiﬁcant.
In addition to HCN1, HCN2 and the HCN-interacting protein
TRIP8b were detected in anti-neuroﬁbromin immunoprecipitates.
However, these proteins were not observed when brains of Hcn1–/–
mice were used for the co-IP. Therefore, we conclude that both
HCN2 and TRIP8b were precipitated through their (known)
interaction with HCN1, rather than through direct binding to
neuroﬁbromin. Moreover, we observed no difference in the total
level of HCN1, HCN2 or TRIP8b when we compared hippocampal
lysates of WT and Nf19a–/9a– mice (Figure 3a).
To further investigate the interaction between HCN1 and NF1,
we performed heterologous expression studies in HEK293T cells.
Cells were co-transfected with a plasmid expressing the N-term-
inal half of NF1 (with or without exon 9a) fused to GFP (NF1-GFP),
together with a plasmid-expressing HCN1. Lysates were subse-
quently used for co-IP with the anti-HCN1 antibody. NF1-GFP was
successfully identiﬁed in the co-IP with the HCN1 antibody.
However, consistent with the co-IP results in hippocampal lysates,
this interaction does not depend on the presence of exon 9a
(Figure 3b). Taken together, these results indicate that NF1
interacts with HCN1 through its N-terminal domain, but the
N-terminal exon 9a is not required for this interaction.
Cell-type-speciﬁc reduction of HCN current in Nf19a–/9a– mice
To examine the functional impact of the interaction between NF1
and HCN1 on hyperpolarization-activated cation current (Ih), we
measured Ih in both inhibitory and excitatory neurons in the
hippocampal CA1 area. We were particularly interested in fast-
spiking parvalbumin (PV)-expressing neurons, given that expres-
sion of HCN123,24 is highly enriched in PV neurons of the
hippocampus. Immunohistochemistry of hippocampal slices
conﬁrmed the presence of both HCN1 and NF1 in PV neurons
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TRIP8b were all co-precipitated with NF1 in the WT and Nf19a–/9a– samples. In the absence of HCN1 (Hcn1–/–), the NF1 antibody is unable to co-
immunoprecipitation (co-IP) HCN2 and TRIP8b. Right panel: hippocampal lysates used as input for IP experiments, showing normal HCN1,
HCN2 and TRIP8b expression in Nf19a–/9a– mice. (b) Co-IP using a monoclonal antibody against HCN1 on lysates made from HEK293T cells co-
transfected with constructs expressing HCN1 and the N-terminal half of NF1 (with or without exon 9a) fused to GFP (representative image;
transfection and IP were repeated two times). Immunoblot analysis was performed with antibodies directed against HCN1 and GFP. (c and d)
Immunoﬂuorescence co-labeling of PV (red) and NF1 (green) (c), or PV (red) and HCN1 (green) (d) in hippocampal sections of WT mice,
showing high expression of NF1 and HCN1 in PV-expressing neurons.
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(Figures 3c and d). We recorded from interneurons with somata
located at the border of stratum pyramidale and oriens. Cells
were identiﬁed as fast-spiking PV neurons based on electro-
physiological characteristics and post-hoc immunoreactivity for PV
(see Supplementary Materials and Methods and Figure 4a).
Hyperpolarizing steps from a holding potential of -50 mV resulted
in slowly activating inward currents (Figure 4b). Ih was pharma-
cologically isolated by subtracting current traces before and after
application of the HCN antagonist ZD7288 (30 μM). Steady-state
current–voltage (I-V) relation showed smaller Ih at more hyperpo-
larized potentials in Nf19a–/9a– mice (Figure 4c). The activation
curve of Ih was obtained by plotting the normalized tail current
amplitude as a function of the voltage step. Fits of the activation
curve with a Boltzmann function yielded a hyperpolarizing shift of
7 mV in the half-activation potential (V1/2) in Nf1
9a–/9a– mice
(-88.4 ± 1.9 mV, n= 10) compared with their WT littermates
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Figure 4. Ih is selectively attenuated in Nf1
9a–/9a– PV neurons. (a) Top: PV immunoreactivity of a biocytin-ﬁlled interneuron shown by
ﬂuorescent double labeling (representative image, repeated for each included interneuron). Bottom: Representative voltage responses of
PV and pyramidal neurons to depolarizing and hyperpolarizing current injections. (b) Sample voltage–clamp recordings from a PV neuron and
a pyramidal neuron. The ZD7288-sensitive Ih currents were obtained by subtracting current traces before and after application of (30 μM)
ZD7288. Currents were evoked by 800ms hyperpolarizing voltage steps from a holding potential of -50 to -120mV in 10mV increments. (c)
The current–voltage (I-V) relationship of Ih is signiﬁcantly shifted toward smaller Ih in Nf1
9a–/9a–PV neurons (F1,16= 4.1, Po0.05, n= 7 and n= 11
for WT and Nf19a–/9a–, respectively). (d) The activation curve of Ih obtained by plotting the normalized tail current amplitude as a function of
the voltage step and ﬁtted with a Boltzmann function (solid lines). There was a signiﬁcant hyperpolarizing shift in the voltage-dependent
activation of Ih in Nf1
9a–/9a– PV neurons (V1/2 in WT was -81.2± 2.0 and -88.4± 1.9 in Nf1
9a–/9a–, Po0.01). (e) The mean number of action
potentials generated in response to depolarizing current pulses in the PV neurons from Nf19a–/9a– is signiﬁcantly higher (F1,22= 4.4, Po0.05).
(f) No signiﬁcant differences were found in the I-V relationship (F1,19= 1.4, P= 0.2) or in (g) the voltage dependence of Ih activation of
pyramidal neurons between genotypes (P= 0.3; n= 9 and n= 10 for WT and Nf19a–/9a–, respectively). (h) Excitability of pyramidal neurons is
unchanged in Nf19a–/9a– mice (F1,32= 0.1, P= 0.8; n= 16 and n= 18 for WT and Nf1
9a–/9a–, respectively). Statistical analyses were performed by
Student’s t-test and two-way ANOVA followed by Tukey's test. *Po0.05, **Po0.01. Data represent the mean± s.e.m.
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(-81.2 ± 2.0 mV, n= 7, Po0.01; Figure 4d). The shift in V1/2
inﬂuenced neither the slope of activation curve (WT:
11.4±1.3mV, P=0.5; Nf19a–/9a–: 11.2±1.4mV) nor the kinetics of Ih
(Supplementary Figure 3).
As HCN1 expression is not restricted to PV interneurons, we
tested if the alterations in Ih are also observed in excitatory
neurons. Hence, we recorded Ih in CA1 pyramidal neurons.
Importantly, no signiﬁcant differences were observed in either
the current–voltage relationship or in the voltage dependence
of Ih between pyramidal neurons from Nf1
9a–/9a– and WT
littermates (Figures 4f and g). Both V1/2 and the slope factor were
also unchanged in pyramidal neurons (-85.9 ± 1.8 and 13.8 ±
0.8 mV (n= 10) for Nf19a–/9a–; -83.9 ± 1.1 mV and 14.3 ± 0.6 mV
(n= 9) for WT, respectively). Furthermore, the Ih kinetics remained
intact (Supplementary Figure 3). Taken together, these ﬁndings
suggest that Nf19a–/9a– mice have a selective reduction of Ih in
GABAergic interneurons.
Several studies have shown that decreases in Ih result in
neuronal hyperexcitability.16,17,20,34 Therefore, we examined
whether neuronal excitability was altered in PV neurons of
Nf19a–/9a– mutants. Current-clamp recordings revealed that PV
neurons of Nf19a–/9a– mice had a signiﬁcantly hyperpolarized
resting membrane potential (-64.1 ± 0.7 mV, n= 17 vs -60.6 ±
0.7 mV, n= 12; Po0.005) and a higher input resistance
(279 ± 19 MΩ, n= 15 vs 235 ± 14 MΩ, n= 16, Po0.05). Next, we
measured the excitability of PV neurons from Nf19a–/9a– and WT
mice. Despite having a hyperpolarized resting membrane
potential, PV neurons from Nf19a–/9a– mice produced a signiﬁ-
cantly greater number of action potentials (Figure 4e). Impor-
tantly, the increase of action potential ﬁring is not likely caused by
alterations in sodium channels as there was no signiﬁcant change
in action potential threshold. Accordingly, other action potential
parameters including peak amplitude, half-width and rise time
were unchanged (Supplementary Table 2).
Given the observed differences in the intrinsic membrane
properties of PV neurons from Nf19a–/9a– mice, we also sought to
quantify these parameters for CA1 pyramidal neurons. In contrast
to PV neurons, neither the resting membrane potential (Nf19a–/9a–:
-68.1 ± 0.9 mV, n= 17 and WT: -66.5 ± 0.8 mV, n= 23; P= 0.2) nor
the input resistance (Nf19a–/9a–: 116 ± 4.5 MΩ, n= 18 and WT:
118 ± 4.5 MΩ, n= 14; P= 0.8) was altered in pyramidal neurons.
In addition, the relative sag amplitude was similar between
genotypes (WT: 1.2 ± 0.03 and Nf19a–/9a–: 1.1 ± 0.02, P= 0.3), as well
as the action potential threshold, peak amplitude, half-width and
rise time (Supplementary Table 2). Moreover, the excitability of
pyramidal neurons was also normal in Nf19a–/9a– mice (Figure 4h),
conﬁrming the highly selective impact of NF1 function in
GABAergic interneurons.
Next, we investigated whether the novel ﬁndings observed in
the Nf19a–/9a– mice also apply to the Nf1+/– mouse model of NF1.3,6
Similar to that in Nf19a–/9a– mice, Ih was smaller in Nf1
+/–PV
neurons, and its activation was shifted toward more hyperpolar-
ized potentials (Supplementary Figures 4a and b). The half-
activation potential for Ih in Nf1
+/–PV neurons was -89.7 ± 1.7 mV
(n= 7) compared with -84.7 ± 1.1 mV (n= 7) from WT littermates
Po0.01. In addition, the average maximal tail current amplitude
was substantially lower in PV neurons of Nf1+/– mice (-65 ± 11 pA)
compared with WT littermates (-96 ± 12 pA; Po0.05), whereas the
slope of activation remained unchanged (Nf1+/–: 10.4 ± 0.8 mV, WT:
9.9 ± 0.7 mV; P= 0.30). Furthermore, as observed for Nf19a–/9a–
mice, the resting membrane potential of Nf1+/–PV neurons was
hyperpolarized (-65.1 ± 1.1 mV, n= 14 vs -61.8 ± 0.8 mV, n= 9;
Po0.05) and the input resistance was elevated (289 ± 15.0 MΩ,
n= 16 vs 258 ± 9.5 MΩ, n= 18; Po0.05). In addition, and
consistent with a signiﬁcant downregulation of Ih, Nf1
+/–PV
neurons showed increased excitability (Supplementary Figure
4c), without any signiﬁcant differences in the characteristics of the
action potential voltage waveform or threshold (Supplementary
Table 3). Finally, and in contrast to the changes observed in PV
neurons, Nf1+/–pyramidal neurons showed no alterations in Ih
amplitude, voltage-dependent activation or intrinsic excitability
(Supplementary Figures 4d–f).
To determine whether other subtypes of interneurons also have
attenuation of Ih, we recorded from stratum oriens-alveolus (OA)
interneurons of the hippocampal CA1 region, a major class of
dendritically targeting interneurons.14 Similar to our ﬁndings in PV
neurons, both Nf19a–/9a– and Nf1+/– mice exhibited a reduction
of Ih in OA interneurons, including the activation being shifted
toward more hyperpolarized potentials (Supplementary Figures 5a
and b). The half-activation potential for Ih in Nf1
9a–/9a– OA inter-
neurons was -89.4 ± 1.4 mV (n= 6) compared with -81.5 ± 2.9 mV
(n= 5) from WT littermates (Po0.05). The half-activation potential
for Ih in Nf1
+/–OA interneurons was -87.4 ± 0.9 mV (n= 10),
compared with -83.1 ± 1.7 mV (n= 7) from WT littermates
(Po0.05). Furthermore, and consistent with a signiﬁcant down-
regulation of Ih, Nf1
9a–/9a– and Nf1+/–OA interneurons were more
excitable than their WT controls (Supplementary Figure 5c).
Previous studies have demonstrated that Nf1+/– mice
have increased GABAergic transmission across multiple brain
regions.35,36 Therefore, we sought to examine whether the
attenuation of Ih in Nf1 mice is restricted to hippocampal
interneurons, or is also evident in other brain regions. We
recorded from layer 1 (L1) interneurons of the visual cortex in
Nf1+/– mice. Given the interneuron subtype diversity in L1,37,38 we
performed Ih recordings from interneurons with similar intrinsic
electrophysiological properties, including the delay of the
threshold spike, AP ﬁring pattern, shape and amplitude of the
after-hyperpolarization, and the amplitude of sag in response to
hyperpolarizing currents. Voltage clamp experiments for Ih
recordings in L1 interneurons were performed using the same
voltage protocols as implemented for the hippocampal inter-
neuron recordings. Similar to that in hippocampal interneurons, Ih
was reduced in L1 interneurons from Nf1+/– mice (Supplementary
Figure 6a). Moreover, and also consistent with our ﬁndings in
hippocampal interneurons, the activation curve of Ih in L1
interneurons exhibited a hyperpolarizing shift of 8 mV in the
half-activation potential in Nf1+/–mice (-88.8 ± 1.5 mV, n= 13)
compared with their WT littermates (-81.0 ± 2.9 mV, n= 8,
Po0.02; Supplementary Figure 6b). Furthermore, and consistent
with a signiﬁcant downregulation of Ih, Nf1
+/–L1 interneurons were
more excitable than their WT controls (Supplementary Figure 6c).
Taken together, our results establish that loss-of-function muta-
tions in Nf1 result in a decrease of Ih in GABAergic interneurons
across multiple brain regions, which potentially represents a
fundamental pathophysiological mechanism underlying NF1.
We next sought to determine whether a change in Ih, is
sufﬁcient to affect GABA release in Nf1 mice. Hippocampal PV
neurons primarily innervate postsynaptic neurons at the soma,
providing strong inhibitory control over the ﬁring properties of
pyramidal neurons.39 Therefore, alterations of the intrinsic
excitability of PV neurons might affect action potential-driven
synaptic GABA release onto pyramidal neurons. Accordingly,
blocking Ih in WT mice would be expected to increase GABAergic
input onto pyramidal neurons and mimic the enhanced inhibition
observed in Nf19a–/9a– mice. Indeed, consistent with our hypo-
thesis, the frequency of spontaneous inhibitory postsynaptic
currents (sIPSCs) recorded in CA1 pyramidal cells of WT mice
was signiﬁcantly increased after application of the HCN channel
antagonist ZD7288 (30 μM; Supplementary Figures 7a and b).
In contrast, no signiﬁcant changes were observed in sIPSC
amplitude (Supplementary Figure 7c). Taken together, these
results support a causal inﬂuence of Ih in regulating inhibitory
output from GABAergic interneurons onto CA1 pyramidal cells.
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Constitutively active H-Ras/ERK signaling in H-RASG12V knock-in
mice does not affect HCN current
NF1 is known to function as a negative regulator of Ras-ERK
signaling. Therefore, to determine whether hyperactivation
of the Ras-ERK pathway can affect HCN function, we made use
of H-RasG12V knock-in mice, which express the constitutively active
H-RasG12V isoform through a targeted mutation of the endogen-
ous H-Ras gene.40 H-Ras is the most prominent Ras isoform in the
brain and is highly expressed in both interneurons and excitatory
neurons.25 H-RasG12V mice showed a dramatic increase of the Ras-
ERK pathway, as measured by the relative level of phosphorylated
ERK1 (212% of WT, Po0.01) and ERK2 (246% of WT, Po0.001) in
the hippocampus, which is far greater than the levels of ERK
activation observed in NF1 mice. However, in contrast to Nf1
mutant mice, the current–voltage relationship and voltage
dependence of Ih in PV neurons were similar between H-Ras
G12V
and WT littermates (Supplementary Figures 8a–c; V1/2: H-Ras
G12V,
-84.7 ± 2.5 mV, n= 6; WT, -87.3 ± 1.7 mV, n= 8; P= 0.3). Further-
more, the slope of activation (H-RasG12V: 13.1 ± 1.2 mVmV, WT:
12.3 ± 0.7 mV; P= 0.54) and the Ih kinetics remained intact.
Consistent with the absence of any detectable changes in Ih,
neither the resting membrane potential (H-RasG12V: -62.5 ± 0.9 mV,
n= 8 and WT: -63.9 ± 1.1 mV, n= 12; P= 0.3) nor the input resi-
stance (H-RasG12V: 257 ± 29.2 MΩ, n= 8 and WT: 233 ± 27.5 MΩ,
n= 12; P= 0.57) was altered in H-RasG12V PV neurons. Moreover,
the excitability of PV neurons was also normal in H-RasG12V mice
(Supplementary Figure 8d). These results show that marked
activation of the Ras-ERK pathway is not sufﬁcient to affect Ih in PV
neurons. Together with previous studies demonstrating that
pharmacological inhibition of the ERK pathway has no effect
onIh in CA1 pyramidal neurons, as well as the absence of any
consensus ERK phosphorylation sites on HCN1 or HCN2,41 these
results suggest that NF1 regulates HCN function through a H-Ras/
ERK-independent mechanism.
The HCN channel agonist, LTG, rescues the electrophysiological
and behavioral phenotypes of Nf1 mice
LTG, a novel anticonvulsant which is known to act on Na+
channels, has been also shown to enhance Ih in pyramidal neurons
through a positive shift in the voltage dependence of Ih activa-
tion.34 Therefore, we investigated whether LTG also enhances
activation of Ih in GABAergic interneurons, and if so, whether it
is able to restore the alterations in interneuron excitability in
Nf1 mice. Ih was recorded in Nf1
9a–/9a–PV neurons in the presence
of LTG (50 μM). Indeed, LTG increased the magnitude of Ih in
Nf19a–/9a–mice and caused a signiﬁcant depolarizing shift in Ih
activation in Nf19a–/9a–PV neurons, which was fully normalized
compared with recordings from WT mice (Figure 5a). The V1/2 in
the presence of LTG was -80.9 ± 2.0 mV (n= 9). LTG did not affect
the slope of activation curve.
Next, we examined whether the LTG-mediated increase in Ih
activation inﬂuences neuronal excitability. In the presence of LTG,
the resting membrane potential of PV neurons was signiﬁcantly
depolarized in both Nf19a–/9a–(3.5 ± 0.5 mV, n= 12) and WT mice
(3.0 ± 0.3 mV, n= 9). Therefore, to examine the effect of LTG on
action potential ﬁring of PV neurons, the resting membrane
potential was compensated to match the period preceding the
application of LTG. Indeed, bath application of LTG caused a
reduction of action potential ﬁring rates in response to depolariz-
ing current injections in Nf19a–/9a–mice (Figure 5b). Furthermore,
LTG application did not signiﬁcantly affect action potential
threshold, peak amplitude, half-width and rise time (Supple-
mentary Table 4). To determine whether the effect of LTG on
membrane excitability was directly mediated via Ih, the HCN
antagonist ZD7288 was applied before application of LTG. In this
condition, the effect of LTG on membrane excitability was fully
blocked (Figure 5b). These results suggest that LTG decreases
membrane excitability by directly increasing Ih activation, rather
than by the blockade of Na+ channels. Notably, this ﬁnding is
entirely consistent with the notion that LTG exerts its antic-
onvulsant action on Na+ channels selectively during periods of
sustained depolarization or repetitive ﬁring, as is the case during
seizures.42,43
By decreasing interneuron excitability, LTG would be expected
to signiﬁcantly reduce inhibitory inputs onto neighboring
pyramidal cells. Therefore, we examined the effect of LTG on
LTP at Schaffer collateral-CA1 synapses. Indeed, LTG restored LTP
in Nf19a–/9a– mice to the level of WT mice, whereas the LTP deﬁcit
remained evident in vehicle-treated slices from Nf19a–/9a– mice
(Figure 5c). Together, our results with LTG provide increasing
support for a causal model of NF1 pathophysiology by which the
interneuron-speciﬁc reduction of Ih enhances GABAergic inhibition
onto CA1 pyramidal neurons, leading to deﬁcits in hippocampal
LTP.
To further validate this model, we sought to determine whether
the behavioral deﬁcits of Nf1 mice can also be rescued by LTG
administration. Mice were given intraperitoneal injections of
vehicle or LTG (25mg kg-1). There was a signiﬁcant effect of
training on the latency to reach the platform, which was not
modiﬁed by genotype or by treatment (Supplementary Figures 9a
and b) and swimming speed was similar between different groups
(Supplementary Figure 9c). As a replication of our previous results
shown in Figure 1c, vehicle-treated Nf19a–/9a–mice showed no
spatial preference for the target quadrant. However, in strong
support of our model of impaired HCN function in Nf19a–/9a– mice,
LTG treatment restored the learning capacity of Nf19a–/9a– mice,
without altering the performance of their WT littermates
(Figure 5d). Furthermore, and consistent with a prominent
inﬂuence of HCN channel function in the pathophysiology of
the Nf1+/– mouse model, Nf1+/– mice treated with LTG also
showed a clear preference for the target quadrant, in contrast to
their vehicle-treated littermates (Figure 5e).
In addition to visual-spatial learning deﬁcits, we recently
demonstrated prominent impairments of motor coordination in
NF1 patients, as well as in Nf1+/–mice.5,44 In particular, Nf1+/–mice
showed impaired learning on the accelerating rotarod, a motor
learning paradigm that does not depend on hippocampal
function. Indeed, LTG treatment completely rescued the motor
coordination deﬁcit in Nf1+/– mice (Supplementary Figure 9d).
Taken together, using two different mouse models and highly
distinct learning tasks, our results implicate the attenuation of
HCN channel function as a novel therapeutic target for the
treatment of cognitive and motor deﬁcits in NF1.
DISCUSSION
Previous studies have shown that the learning and plasticity
deﬁcits of Nf1+/– mice result from enhanced neuronal inhibition,3,6
suggesting that GABAergic interneurons are selectively impacted
by NF1 loss-of-function mutations. Here, we developed a neuron-
speciﬁc NF1 exon 9a mutant (Nf19a–/9a–), in order to more
speciﬁcally explore the neuronal pathophysiology underlying
NF1. Nf19a–/9a– mice showed the same pathophysiological pheno-
type as the Nf1+/– mice. By using proteomics and electrophysio-
logical techniques, we identiﬁed a cell-type-speciﬁc attenuation of
Ih in GABAergic interneurons, which strongly contributes to the
observed enhanced inhibition in Nf1 loss-of-function mice.
Importantly, we found that stimulating HCN current with the
clinically approved drug LTG rescues the deﬁcits in synaptic
plasticity, motor performance and spatial learning in both
Nf19a–/9a– and Nf1+/- mice.
Our ﬁndings suggest that Ih could be an important modulator of
synaptic plasticity and spatial memory by regulating inhibitory
outputs. Consistent with this notion, blocking HCN channels
resulted in increased frequency of sIPSCs in pyramidal neurons. As
HCN channels are a therapeutic target for NF1
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the majority of spontaneous inhibitory events onto hippocampal
pyramidal neurons arise from perisomatic inhibition,45,46 it is likely
that the increased frequency of sIPSCs is predominantly mediated
by PV neurons. However, the contribution of other interneurons
subtypes, including dendritically targeting interneurons such as
OA interneurons, cannot be excluded.
Notably, in both Nf1 mutants, we observed a downregulation of
Ih associated with increased excitability of GABAergic interneur-
ons. In particular, we observed a decrease of Ih and corresponding
increase of intrinsic excitability in all three types of interneurons
tested in this study: hippocampal PV interneurons, hippocampal
OA interneurons and L1 visual cortex interneurons. This suggests
that the interneuron-speciﬁc impairment of HCN function is
evident in a wide diversity of interneuron subtypes across multiple
brain regions. Our ﬁnding that a reduction in Ih was consistently
associated with an increase of intrinsic excitability is also con-
sistent with previous reports in pyramidal neurons where down-
regulation of Ih increased EPSP amplitude, temporal summation
and intrinsic excitability.16,20,47 The regulatory effect of Ih on
membrane excitability has been attributed to its partial activity at
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Figure 5. Lamotrigine (LTG) rescues the electrophysiological and behavioral phenotypes in Nf19a–/9a– mice. (a) Left: Ih amplitude is signiﬁcantly
increased by LTG in Nf19a–/9a–mice (F1,21= 9.9, Po0.05, n= 12). Right: LTG shifts Ih activation to more depolarized potentials in PV neurons from
Nf19a–/9a– mice. Control data are the same as shown in Figures 4c and d. Dashed line shows activation curve for wild-type (WT) littermates. (b)
LTG decreases membrane excitability in PV neurons from Nf19a–/9a– mice and this effect is blocked by ZD7288. Left: sample recordings of APs
elicited by a depolarizing current step before and after application of LTG in the absence and presence of ZD7288. Right: summary graph of
change in ﬁring rates caused by LTG, in the absence and presence of ZD7288, as a function of injected current. (c) Left: LTP at SC-CA1 synapses
is impaired in vehicle-treated slices from Nf19a–/9a– mice (n= 9) compared with WT mice (n= 6, Po0.01). Right: LTG rescues the LTP deﬁcit in
Nf19a–/9a– mice (n= 10 and n= 16 for WT and Nf19a–/9a–, respectively, P= 0.2). (d) LTG rescues the learning deﬁcits in Nf19a–/9a– mice in a water
maze probe trial, (two-way analysis of variance (ANOVA), genotype ×drug interaction, F1,43= 6.0, Po0.05). The black and white columns
represent the target quadrant (TQ) and average time spent in other quadrants, respectively. Although vehicle-treated Nf19a–/9a– mice (n= 9)
spend only 27% of their time in the TQ, LTG-treated Nf19a–/9a– mice (n= 12) show 45% TQ preference (Po0.05). LTG has no signiﬁcant effect on
spatial learning in WT mice (vehicle, n= 12 and LTG, n= 14, P= 0.3). (e) LTG rescues the spatial learning deﬁcits of Nf1+/–mutants (two-way
ANOVA, genotype ×drug interaction, F1,40= 5.2, Po0.05). Vehicle-treated Nf1+/– mice show no preference for the TQ (25%, n= 9), whereas
LTG-treated Nf1+/– mice show robust learning (44%, n= 10; Po0.05). LTG has no signiﬁcant effect on WTmice (Vehicle, n= 13, and LTG, n= 12;
P= 0.4). The heatplots are visual representation of all search tracks, in which the color indicates the mean time spent at a certain
position. Statistical analyses were performed by Student’s t-test and two-way ANOVA followed by Tukey's test. *Po0.05. Data represent the
mean± s.e.m.
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resting membrane potentials, resulting in a shunt conductance,
which decreases the temporal integration of EPSPs.16,34 In
addition, HCN channels have been shown to provide a tonic
depolarizing current that increases resting activation of the
delayed-rectiﬁer M-type K+ channels along with inactivation of
N- and T-type voltage-gated Ca2+ channels.48,49
Currently, there are no speciﬁc agonists for HCN channels.
Therefore, we used the commonly prescribed anticonvulsant LTG,
which is well established to enhance Ih and decrease excitability in
pyramidal neurons.34 Although LTG is also known to inhibit Na+
channels, it acts mainly on the slow inactivated state with no
effect on the resting, closed state.42,43 This suggests that LTG, at
clinically relevant concentrations, exerts its anticonvulsant action
on Na+ channels upon prolonged depolarization or repetitive
ﬁring conditions, as is the case during seizures. Accordingly, we
observed no signiﬁcant changes in LTP or learning with LTG
treatment in WT mice. Furthermore, the LTG-induced decrease in
membrane excitability was not associated with a change in action
potential parameters and it was blocked by prior application of
the highly speciﬁc HCN antagonist ZD7288, suggesting that LTG
conferred its action mainly through Ih rather than through
changes in sodium channel conductance.
Although inhibition of Ras/ERK signaling has previously been
shown to be sufﬁcient to reverse the increased inhibition and
cognitive deﬁcits in Nf1 mutant mice,3,6,29 the particularly large
size and multi-domain structure of NF1 have led many investiga-
tors to hypothesize that NF1 might have functions beyond its well-
established role as a negative regulator of Ras signaling. Here, we
have shown that NF1 interacts with HCN1 through its N-terminus,
and that mutations in NF1 affect HCN channel function. The
regulation of HCN channels could be Ras independent, as HCN
channels lack ERK consensus phosphorylation sites and Ih is not
affected by MEK inhibitors.41 Moreover, using H-RasG12V knock-in
mice (a mouse model for Costello syndrome), we show that a
marked increase of Ras-ERK signaling is insufﬁcient to change Ih in
interneurons. Recently, a mouse model of Noonan syndrome has
been described, which demonstrated that upregulation of the ERK
signaling pathway causes learning and LTP deﬁcits, which are at
least in part mediated by increased glutamatergic synaptic
transmission.50 Hence, the interneuron-speciﬁc phenotype of
NF1 does not seem to be common phenotype of the Rasopathy
family, which could indicate a distinct, Ras-independent function
of the NF1 protein. A Ras-independent function of neuronal NF1
has been previously identiﬁed in the Drosophila model of NF1, and
in neuronal cultures from Nf1 mice, through alterations in cyclic
adenosine monophosphate (cAMP) signaling.51–53 Given that HCN
channels are well-known to be regulated by cAMP,13 it is distinctly
possible that the HCN1–NF1 interaction affects local changes in
cAMP, which contribute to the attenuated Ih current in
interneurons of Nf1 mice.54 Further studies are needed to address
these possibilities. From a therapeutic perspective, it is notable
that normalization of both Ras/ERK signaling and HCN function
appear sufﬁcient to rescue the electrophysiological and learning
deﬁcits in mice. However, as targeted downregulation of Ras/ERK
signaling have shown no evidence of clinical efﬁcacy in children
with NF1,8,9 targeting the HCN-dependent increase in the
excitability of inhibitory neurons might have important therapeu-
tic implications for the treatment of NF1 patients, either as
monotherapy or in combination with Ras/ERK inhibitors.
Taken together, using two different Nf1 loss-of-function mutants,
we have elucidated a novel cell-type-speciﬁc pathophysiological
mechanism underlying NF1, by which interneuron excitability,
synaptic plasticity, cognitive function and motor coordination can
all be rescued by the clinically approved HCN agonist LTG.
Therefore, HCN channels are a highly promising drug target for
treating the cognitive deﬁcits associated with NF1.
CONFLICT OF INTEREST
The authors declare no conﬂict of interest.
ACKNOWLEDGMENTS
We thank Dr Nolan for providing the HCN-KO brain samples, Dr Chetkovich for the
guinea pig HCN1 antibody, Dr Siegelbaum for the HCN1 constructs, Dr Guerra and Dr
Barbacid for the H-RasG12V mice, and TEVA Pharmaceuticals for providing LTG. We are
grateful to the following people for their assistance: M Aghadavoud Jolfaei (ﬁeld-
recording and genotyping), E Haasdijk and E Goedknegt (immunohistochemistry), M
Elgersma, U Unmehopa and D Swaab (in-situ hybridizations), RC van der Schors (mass
spectrometry), Kelly Diggs-Andrews (NF1 western blot) and R Bari (cloning Nf1 9a
gene). We thank Gerard Borst for advice and critical reading of the manuscript. This
work was supported by a Children Tumor Foundation (CTF) young investigator award
to AO, by grants from the Netherlands Brain Foundation (HsN) and NWO-ZonMW
(VICI) to YE, a Department of Defense grant to DHG, HEALTH-2009-2.1.2-1 EU-FP7
SYNSYS to ABS and KWL, and a FES-NEUROBASIC grant to CNL, ABS, SAK and YE.
AUTHOR CONTRIBUTIONS
AO conducted electrophysiology experiments, immunohistochemistry and data
analysis. YE generated the Nf19a–/9a– mouse in the laboratory of AJS. TvdV
carried out behavioral experiments and data analysis. GvW and EM performed
biochemical experiments and immunohistochemistry. MRH contributed to ﬁeld-
potential recordings. KWL conducted proteomics experiments and data
analysis. DHG, ABS, CNL and AJS provided critical insight and reagents. AO,
SAK and YE designed the study and wrote the manuscript with input from all
authors.
REFERENCES
1 Krab LC, Aarsen FK, de Goede-Bolder A, Catsman-Berrevoets CE, Arts WF, Moll HA
et al. Impact of neuroﬁbromatosis type 1 on school performance. J Child Neurol
2008; 23: 1002–1010.
2 Hyman SL, Shores A, North KN. The nature and frequency of cognitive deﬁcits in
children with neuroﬁbromatosis type 1. Neurology 2005; 65: 1037–1044.
3 Costa RM, Federov NB, Kogan JH, Murphy GG, Stern J, Ohno M et al. Mechanism
for the learning deﬁcits in a mouse model of neuroﬁbromatosis type 1. Nature
2002; 415: 526–530.
4 Silva AJ, Frankland PW, Marowitz Z, Friedman E, Laszlo GS, Ciofﬁ D et al. A mouse
model for the learning and memory deﬁcits associated with neuroﬁbromatosis
type I. Nat Genet 1997; 15: 281–284.
5 van der Vaart T, van Woerden GM, Elgersma Y, de Zeeuw CI, Schonewille M. Motor
deﬁcits in neuroﬁbromatosis type 1 mice: the role of the cerebellum. Genes Brain
Behav 2011; 10: 404–409.
6 Cui Y, Costa RM, Murphy GG, Elgersma Y, Zhu Y, Gutmann DH et al. Neuroﬁbromin
regulation of ERK signaling modulates GABA release and learning. Cell 2008; 135:
549–560.
7 Ye X, Carew TJ. Small G protein signaling in neuronal plasticity and memory
formation: the speciﬁc role of ras family proteins. Neuron 2010; 68: 340–361.
8 Krab LC, de Goede-Bolder A, Aarsen FK, Pluijm SM, Bouman MJ, van der Geest JN
et al. Effect of simvastatin on cognitive functioning in children with neuroﬁ-
bromatosis type 1: a randomized controlled trial. JAMA 2008; 300: 287–294.
9 van der Vaart T, Plasschaert E, Rietman AB, Renard M, Oostenbrink R, Vogels A
et al. Simvastatin for cognitive deﬁcits and behavioural problems in patients with
neuroﬁbromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial.
Lancet Neurol 2013; 12: 1076–1083.
10 Geist RT, Gutmann DH. Expression of a developmentally-regulated neuron-spe-
ciﬁc isoform of the neuroﬁbromatosis 1 (NF1) gene. Neurosci Lett 1996; 211:
85–88.
11 Gutmann DH, Zhang Y, Hirbe A. Developmental regulation of a neuron-speciﬁc
neuroﬁbromatosis 1 isoform. Ann Neurol 1999; 46: 777–782.
12 Danglot G, Regnier V, Fauvet D, Vassal G, Kujas M, Bernheim A. Neuroﬁbromatosis
1 (NF1) mRNAs expressed in the central nervous system are differentially spliced
in the 5' part of the gene. Hum Mole Genet 1995; 4: 915–920.
13 Wahl-Schott C, Biel M. HCN channels: structure, cellular regulation and physio-
logical function. Cell Mol Life Sci 2009; 66: 470–494.
14 Maccaferri G, McBain CJ. The hyperpolarization-activated current (Ih) and its
contribution to pacemaker activity in rat CA1 hippocampal stratum oriens-alveus
interneurones. J Physiol 1996; 497: 119–130.
15 Lupica CR, Bell JA, Hoffman AF, Watson PL. Contribution of the hyperpolarization-
activated current (I(h)) to membrane potential and GABA release in hippocampal
interneurons. J Neurophysiol 2001; 86: 261–268.
HCN channels are a therapeutic target for NF1
A Omrani et al
10
Molecular Psychiatry (2015), 1 – 11 © 2015 Macmillan Publishers Limited
16 Magee JC. Dendritic Ih normalizes temporal summation in hippocampal CA1
neurons. Nat Neurosci 1999; 2: 848.
17 Nolan MF, Malleret G, Dudman JT, Buhl DL, Santoro B, Gibbs E et al. A behavioral
role for dendritic integration: HCN1 channels constrain spatial memory and
plasticity at inputs to distal dendrites of CA1 pyramidal neurons. Cell 2004; 119:
719–732.
18 Wang M, Ramos BP, Paspalas CD, Shu Y, Simen A, Duque A et al. Alpha2A-
adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN
channel signaling in prefrontal cortex. Cell 2007; 129: 397–410.
19 Brager DH, Akhavan AR, Johnston D. Impaired dendritic expression and fmr1(-)
(/y) plasticity of h-channels in the mouse model of fragile X syndrome. Cell Rep
2012; 1: 225–233.
20 Shah MM, Anderson AE, Leung V, Lin X, Johnston D. Seizure-induced plasticity of
h channels in entorhinal cortical layer III pyramidal neurons. Neuron 2004; 44:
495–508.
21 Fan Y, Fricker D, Brager DH, Chen X, Lu HC, Chitwood RA et al. Activity-dependent
decrease of excitability in rat hippocampal neurons through increases in I(h). Nat
Neurosci 2005; 8: 1542–1551.
22 Notomi T, Shigemoto R. Immunohistochemical localization of Ih channel subunits,
HCN1-4, in the rat brain. J Comp Neurol 2004; 471: 241–276.
23 Bender RA, Brewster A, Santoro B, Ludwig A, Hofmann F, Biel M et al. Differential
and age-dependent expression of hyperpolarization-activated, cyclic nucleotide-
gated cation channel isoforms 1-4 suggests evolving roles in the developing rat
hippocampus. Neuroscience 2001; 106: 689–698.
24 Brewster AL, Chen Y, Bender RA, Yeh A, Shigemoto R, Baram TZ. Quantitative
analysis and subcellular distribution of mRNA and protein expression of the
hyperpolarization-activated cyclic nucleotide-gated channels throughout devel-
opment in rat hippocampus. Cereb Cortex 2007; 17: 702–712.
25 Sugino K, Hempel CM, Miller MN, Hattox AM, Shapiro P, Wu C et al. Molecular
taxonomy of major neuronal classes in the adult mouse forebrain. Nat Neurosci
2006; 9: 99–107.
26 Zeng H, Shen EH, Hohmann JG, Oh SW, Bernard A, Royall JJ et al. Large-scale
cellular-resolution gene proﬁling in human neocortex reveals species-speciﬁc
molecular signatures. Cell 2012; 149: 483–496.
27 van Woerden GM, Harris KD, Hojjati MR, Gustin RM, Qiu S, de Avila Freire R et al.
Rescue of neurological deﬁcits in a mouse model for Angelman syndrome by
reduction of alphaCaMKII inhibitory phosphorylation. Nat Neurosci 2007; 10:
280–282.
28 Ozonoff S. Cognitive impairment in neuroﬁbromatosis type 1. Am J Med Genet
1999; 89: 45–52.
29 Li W, Cui Y, Kushner SA, Brown RA, Jentsch JD, Frankland PW et al. The HMG-CoA
reductase inhibitor lovastatin reverses the learning and attention deﬁcits in a
mouse model of neuroﬁbromatosis type 1. Curr Biol 2005; 15: 1961–1967.
30 Larson J, Wong D, Lynch G. Patterned stimulation at the theta frequency is
optimal for the induction of hippocampal long-term potentiation. Brain Res 1986;
368: 347–350.
31 Chapman CA, Perez Y, Lacaille JC. Effects of GABA(A) inhibition on the expression
of long-term potentiation in CA1 pyramidal cells are dependent on tetanization
parameters. Hippocampus 1998; 8: 289–298.
32 Bollag G, McCormick F, Clark R. Characterization of full-length neuroﬁbromin:
tubulin inhibits Ras GAP activity. EMBO J 1993; 12: 1923–1927.
33 Gregory PE, Gutmann DH, Mitchell A, Park S, Boguski M, Jacks T et al. Neuroﬁ-
bromatosis type 1 gene product (neuroﬁbromin) associates with microtubules.
Somat Cell Mol Genet 1993; 19: 265–274.
34 Poolos NP, Migliore M, Johnston D. Pharmacological upregulation of h-channels
reduces the excitability of pyramidal neuron dendrites. Nat Neurosci 2002; 5:
767–774.
35 Molosh AI, Johnson PL, Spence JP, Arendt D, Federici LM, Bernabe C et al. Social
learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-
activated kinase. Nat Neurosci 2014; 17: 1583–1590.
36 Shilyansky C, Karlsgodt KH, Cummings DM, Sidiropoulou K, Hardt M, James AS
et al. Neuroﬁbromin regulates corticostriatal inhibitory networks during working
memory performance. Proc Natl Acad Sci USA 2010; 107: 13141–13146.
37 Lee S, Hjerling-Lefﬂer J, Zagha E, Fishell G, Rudy B. The largest group of superﬁcial
neocortical GABAergic interneurons expresses ionotropic serotonin receptors.
J Neurosci 2010; 30: 16796–16808.
38 Rudy B, Fishell G, Lee S, Hjerling-Lefﬂer J. Three groups of interneurons account
for nearly 100% of neocortical GABAergic neurons. Deve Neurobiol 2011; 71:
45–61.
39 Pawelzik H, Hughes DI, Thomson AM. Physiological and morphological diversity of
immunocytochemically deﬁned parvalbumin- and cholecystokinin-positive
interneurones in CA1 of the adult rat hippocampus. J Comp Neurol 2002; 443:
346–367.
40 Schuhmacher AJ, Guerra C, Sauzeau V, Canamero M, Bustelo XR, Barbacid M. A
mouse model for Costello syndrome reveals an Ang II-mediated hypertensive
condition. J Clin Invest 2008; 118: 2169–2179.
41 Poolos NP, Bullis JB, Roth MK. Modulation of h-channels in hippocampal pyr-
amidal neurons by p38 mitogen-activated protein kinase. J Neurosci 2006; 26:
7995–8003.
42 Kuo CC, Lu L. Characterization of lamotrigine inhibition of Na+ channels in rat
hippocampal neurones. Br J Pharmacol 1997; 121: 1231–1238.
43 Xie X, Lancaster B, Peakman T, Garthwaite J. Interaction of the antiepileptic drug
lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na
+ channels in rat hippocampal neurones. Pﬂugers Archiv: Eur J Physiol 1995; 430:
437–446.
44 Krab LC, de Goede-Bolder A, Aarsen FK, Moll HA, De Zeeuw CI, Elgersma Y et al.
Motor learning in children with neuroﬁbromatosis type I. Cerebellum 2011; 10:
14–21.
45 Miles R, Toth K, Gulyas AI, Hajos N, Freund TF. Differences between somatic and
dendritic inhibition in the hippocampus. Neuron 1996; 16: 815–823.
46 Soltesz I, Smetters DK, Mody I. Tonic inhibition originates from synapses close to
the soma. Neuron 1995; 14: 1273–1283.
47 Brager DH, Johnston D. Plasticity of intrinsic excitability during long-term
depression is mediated through mGluR-dependent changes in I(h) in hippo-
campal CA1 pyramidal neurons. J Neurosci 2007; 27: 13926–13937.
48 George MS, Abbott LF, Siegelbaum SA. HCN hyperpolarization-activated cation
channels inhibit EPSPs by interactions with M-type K(+) channels. Nat Neurosci
2009; 12: 577–584.
49 Tsay D, Dudman JT, Siegelbaum SA. HCN1 channels constrain synaptically evoked
Ca2+ spikes in distal dendrites of CA1 pyramidal neurons. Neuron 2007; 56:
1076–1089.
50 Lee YS, Ehninger D, Zhou M, Oh JY, Kang M, Kwak C et al. Mechanism and
treatment for learning and memory deﬁcits in mouse models of Noonan syn-
drome. Nat Neurosci 2014; 17: 1736–1743.
51 Brown JA, Gianino SM, Gutmann DH. Defective cAMP generation underlies the
sensitivity of CNS neurons to neuroﬁbromatosis-1 heterozygosity. J Neurosci 2010;
30: 5579–5589.
52 The I, Hannigan GE, Cowley GS, Reginald S, Zhong Y, Gusella JF et al. Rescue of a
Drosophila NF1 mutant phenotype by protein kinase A. Science 1997; 276: 791–794.
53 Tong J, Hannan F, Zhu Y, Bernards A, Zhong Y. Neuroﬁbromin regulates G protein-
stimulated adenylyl cyclase activity. Nat Neurosci 2002; 5: 95–96.
54 Stowe IB, Mercado EL, Stowe TR, Bell EL, Oses-Prieto JA, Hernandez H et al.
A shared molecular mechanism underlies the human rasopathies Legius syn-
drome and Neuroﬁbromatosis-1. Genes Dev 2012; 26: 1421–1426.
Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)
HCN channels are a therapeutic target for NF1
A Omrani et al
11
© 2015 Macmillan Publishers Limited Molecular Psychiatry (2015), 1 – 11
